The two articles in this month’s
press of The Journal of Arthritis, one by Ekinci et al. titled ‘A New Treatment
Option in Osteoarthritis: Prolotherapy Injections’ and the other by Senatorov
et al.
Titled ‘Clinical Outcome of Hylan
G-F 20 Injections in Shoulder and Hip Osteoarthritis: A Retrospective Review’
raise several important points surrounding the topic of intra-articular
injections. Firstly that there is a paucity of high quality literature in
the field that often leads to inconclusive or misrepresented
conclusions on drug efficacy in established treatments.
The articles also highlight the
heterogeneity in injection procedure, site, concentration, preparation and
outcome measurements. This editorial will, therefore, provide a concise review
on some of the current injection therapies and suggest possible improvements to
methodological structure to inspire readers strive for high quality data.